Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy. [electronic resource]
Producer: 20160614Description: e0142190 p. digitalISSN:- 1932-6203
- Adenocarcinoma -- drug therapy
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Bevacizumab -- pharmacology
- Cell Line, Tumor
- Colorectal Neoplasms -- drug therapy
- Disease Models, Animal
- HT29 Cells
- Humans
- Male
- Mice
- Mice, Inbred C57BL
- Non-Randomized Controlled Trials as Topic
- Treatment Outcome
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.